Dashboard
Manage Tickers

PFE


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
"Florida Discourages Use Of mRNA Covid Vac...
09/13/2024 17:21:41

https://www.nbcnews.com/health/health-news/florida-covid-shots-mrna-vaccines-older-adults-rcna170997Even as the Covid wave in F...

Core News & Articles
North Dakota Judge Overturns State's Abort...
09/12/2024 17:53:13

- Reuters

unitedhealth-follows-competitors-replaces-humira-with-lower-cost-biosimilars
UnitedHealth Follows Competitors, Replaces...
09/11/2024 18:59:13

UnitedHealth will remove AbbVie's Humira from its preferred drug lists by 2025, opting for lower-cost biosimilars like Amge...

gsk-halts-herpes-simplex-virus-vaccine-development-clears-path-for-other-contenders-like-moderna-biontech
GSK Halts Herpes Simplex Virus Vaccine Dev...
09/11/2024 16:13:09

GSK Plc has halted development of its herpes simplex virus vaccine, GSK3943104, after it failed to meet efficacy goals in clini...

enliven-therapeutics-leukemia-candidate-could-challenge-pfizer-astrazeneca-in-broader-target-market-analyst
Enliven Therapeutics' Leukemia Candidate C...
09/09/2024 18:05:21

HC Wainwright initiated coverage on Enliven Therapeutics, noting its innovative small molecules for tumor treatments. HC Wainwr...

why-is-moderna-stock-trading-higher-on-monday
Why Is Moderna Stock Trading Higher On Mon...
09/09/2024 17:00:47

Moderna's Laval, Quebec, facility received a Drug Establishment License from Health Canada, allowing it to produce mRNA vac...

cantor-fitzgerald-reiterates-overweight-on-pfizer-maintains-45-price-target
Cantor Fitzgerald Reiterates Overweight on...
09/09/2024 15:56:03

Cantor Fitzgerald analyst Louise Chen reiterates Pfizer (NYSE:PFE) with a Overweight and maintains $45 price target.

relay-therapeutics-advances-towards-pivotal-trial-as-it-shares-encouraging-breast-cancer-data-in-heavily-pretreated-patients
Relay Therapeutics Advances Towards Pivota...
09/09/2024 15:30:00

Monday, Relay Therapeutics Inc. (NASDAQ:RLAY) shared interim data for RLY-2608 from ReDiscover study, an ongoing first-in-human...

bicycle-therapeutics-lead-cancer-candidates-has-high-opportunity-analyst-initiates-with-bullish-tone
Bicycle Therapeutics' Lead Cancer Candidat...
09/06/2024 17:37:16

RBC Capital initiates coverage on Bicycle Therapeutics, highlighting Zelenectide's potential in oncology with improved safe...

fda-battles-backlog-of-drug-factory-inspections-since-covid-19
FDA Battles Backlog of Drug Factory Inspec...
09/06/2024 15:52:51

FDA faces inspection backlog with serious public health implications, as critical drug manufacturing plants remain unchecked.

whats-going-on-with-penny-stock-blood-cancer-focused-vor-biopharma-on-friday
What's Going On With Penny Stock Blood Can...
09/06/2024 13:35:08

Vor Biopharma reveals promising Phase 1/2 study results for AML treatment, and it is planning FDA pivotal trial discussions.

fake-ozempic-targets-weight-loss-market-forged-batches-an-international-concern
Fake Ozempic Targets Weight-Loss Market: F...
09/05/2024 17:17:20

Criminals distribute fake Ozempic by forging batch numbers. Novo Nordisk suspects one source in global counterfeiting operation...

psychedelic-drugs-market-set-to-grow-by-137b-by-2028-driven-by-mental-health-disorders-and-ai-integration
Psychedelic Drugs Market Set To Grow By $1...
09/05/2024 16:53:46

The global psychedelic drugs market is projected to grow by USD 1.37 billion by 2028, driven by mental health needs and AI adva...

ascendis-pharma-faces-challenges-with-skytrofa-and-yorvipath-pricing-analysts-weigh-in
Ascendis Pharma Faces Challenges With Skyt...
09/04/2024 21:02:35

Ascendis Pharma reported disappointing Q2 sales of $38.76 million, missing the consensus of $92.7 million. Key updates included...

Core News & Articles
MHRA Finds No Evidence Supporting Link Bet...
09/04/2024 14:52:07

- Reuters 

acepodia-enters-strategic-clinical-collaboration-with-pfizer-ignite-to-support-development-of-its-therapies-in-autoimmune-diseases
Acepodia Enters Strategic Clinical Collabo...
09/03/2024 21:04:34

Under this new agreement, Pfizer Ignite will provide strategic guidance and resources to Acepodia as the company develops its c...

uk-taiwan-approve-modernas-updated-covid-19-shot
UK, Taiwan Approve Moderna's Updated COVID...
09/03/2024 18:39:51

The Medicines and Healthcare Products Regulatory Agency has approved Moderna's updated COVID-19 vaccine targeting the JN.1 ...

pfizer-and-valneva-partnered-lyme-disease-vaccine-shows-effectiveness-as-booster-shot-in-mid-stage-study
Pfizer And Valneva Partnered Lyme Disease ...
09/03/2024 18:37:07

Valneva and Pfizer released data from their Phase 2 study of the Lyme disease vaccine candidate VLA15, showing strong immune re...

vaxcyte-shoals-technologies-polestar-automotive-applied-optoelectronics-and-other-big-stocks-moving-higher-on-tuesday
Vaxcyte, Shoals Technologies, Polestar Aut...
09/03/2024 14:47:56

bacterial-infections-vaccine-developer-vaxcytes-pneumococcal-shot-shows-promise-in-mid-stage-trial-stock-shoots-higher
Bacterial Infections Vaccine Developer Vax...
09/03/2024 13:40:49

Vaxcyte announced positive topline results from its Phase 1/2 study of VAX-31, a 31-valent pneumococcal conjugate vaccine candi...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION